Activity of botulinum neurotoxin type D (strain 1873) in human neurons

Toxicon

Volumn 101, Issue , 2015, Pages 63-69

  Pellett, Sabine ^a   Tepp, William H ^a   Scherf, Jacob M ^a   Pier, Christina L ^a   Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

BoNT D; Botulinum neurotoxin; Botulinum neurotoxin D; Clostridium botulinum type D

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN D; BOTULINUM TOXIN E; SYNAPTOBREVIN 2; UNCLASSIFIED DRUG; BOTULINUM TOXIN TYPE D; SYNAPTOBREVIN 1; VAMP1 PROTEIN, HUMAN; VAMP2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOTULISM; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL CULTURE; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROTOXICOLOGY; NEWBORN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; SEROTYPE; SPINAL CORD NERVE CELL; TOXICOKINETICS; TOXIN ANALYSIS; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; INDUCED PLURIPOTENT STEM CELL; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; NERVE CELL;

BOS; CLOSTRIDIUM BOTULINUM; EQUIDAE; MUS; RODENTIA;

ANIMALS; BOTULINUM TOXINS; BOTULISM; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED ICR; NEURONS; VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2;

EID: 84929376744     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2015.04.015     Document Type: Article

References (37)

1. J. Anderson, P.T. Williams, A.M. Katos, M. Krasna, W. Burrows, and C.J. Hilmas CHAPTER 30-botulinum toxin C.G. Ramesh, Handbook of Toxicology of Chemical Warfare Agents 2009 Academic Press San Diego 407 432
2. S.S. Arnon, R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, J. Hauer, M. Layton, S. Lillibridge, M.T. Osterholm, T. O'Toole, G. Parker, T.M. Perl, P.K. Russell, D.L. Swerdlow, K. Tonat Working Group on Civilian B Botulinum toxin as a biological weapon: medical and public health management JAMA: J. Am. Med. Assoc. 285 2001 1059 1070
3. S. Bade, A. Rummel, C. Reisinger, T. Karnath, G. Ahnert-Hilger, H. Bigalke, and T. Binz Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates J. Neurochem. 91 2004 1461 1472
4. S.M. Bajjalieh, G.D. Frantz, J.M. Weimann, S.K. McConnell, and R.H. Scheller Differential expression of synaptic vesicle protein 2 (SV2) isoforms J. Neurosci.: Official J. Soc. Neurosci. 14 1994 5223 5235
5. J.A. Coffield, N. Bakry, R.D. Zhang, J. Carlson, L.G. Gomella, and L.L. Simpson In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches J. Pharmacol. Exp. Ther. 280 1997 1489 1498
6. J. Demarchi, C. Mourgues, J. Orio, and A.R. Prevot Existence of type D botulism in man Bull. l'Academie Natl. Med. 142 1958 580 582
7. D. Dressler Clinical applications of botulinum toxin Curr. Opin. Microbiol. 15 2012 325 336 England
8. R. Eleopra, C. Montecucco, G. Devigili, C. Lettieri, S. Rinaldo, L. Verriello, M. Pirazzini, P. Caccin, and O. Rossetto Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study Clin. Neurophysiol. 124 2013 999 1004
9. D.F. Gimenez, and J.A. Gimenez The typing of botulinal neurotoxins Int. J. food Microbiol. 27 1995 1 9
10. Y. Gong, Y. Tagawa, M.P. Lunn, W. Laroy, M. Heffer-Lauc, C.Y. Li, J.W. Griffin, R.L. Schnaar, and K.A. Sheikh Localization of major gangliosides in the PNS: implications for immune neuropathies Brain 125 2002 2491 2506
11. E.A. Johnson, and C. Montecucco Chapter 11 botulism G.E. Andrew, Handbook of Clinical Neurology Vol. 91 2008 Elsevier 333 368
12. N.E. Kman, and R.N. Nelson Infectious agents of bioterrorism: a review for emergency physicians Emerg. Med. Clin. N. Am. 26 2008 517 547 x-xi
13. A.R. Kroken, A.P. Karalewitz, Z. Fu, J.J. Kim, and J.T. Barbieri Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons J. Biol. Chem. 286 2011 26828 26837
14. M. Kruger, A. Grosse-Herrenthey, W. Schrodl, A. Gerlach, and A. Rodloff Visceral botulism at dairy farms in Schleswig Holstein, Germany: prevalence of Clostridium botulinum in feces of cows, in animal feeds, in feces of the farmers, and in house dust Anaerobe 18 2012 221 223
15. J.Y. Li, L. Edelmann, R. Jahn, and A. Dahlstrom Axonal transport and distribution of synaptobrevin I and II in the rat peripheral nervous system J. Neurosci. 16 1996 137 147
16. M. Lindstrom, J. Myllykoski, S. Sivela, and H. Korkeala Clostridium botulinum in cattle and dairy products Crit. Rev. Food Sci. Nutr. 50 2010 281 304
17. C.J. Malizio, M.C. Goodnough, and E.A. Johnson Purification of Clostridium botulinum type A neurotoxin Methods Mol. Biol. Clift. NJ 145 2000 27 39
18. L.J. Moberg, and H. Sugiyama Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex Appl. Environ. Microbiol. 35 1978 878 880
19. K. Ogawa-Goto, N. Funamoto, T. Abe, and K. Nagashima Different ceramide compositions of gangliosides between human motor and sensory nerves J. Neurochem. 55 1990 1486 1493
20. S. Pellett, W.H. Tepp, C.M. Clancy, G.E. Borodic, and E.A. Johnson A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies FEBS Lett. 581 2007 4803 4808
21. S. Pellett, W.H. Tepp, S.I. Toth, and E.A. Johnson Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination J. Pharmacol. Toxicol. Methods 61 2010 304 310
22. R. Pellizzari, S. Mason, C.C. Shone, and C. Montecucco The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F FEBS Lett. 409 1997 339 342
23. L. Peng, W.H. Tepp, E.A. Johnson, and M. Dong Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors PLoS Pathog. 7 2011 e1002008
24. L. Peng, M. Adler, A. Demogines, A. Borrell, H. Liu, L. Tao, W.H. Tepp, S.C. Zhang, E.A. Johnson, S.L. Sawyer, and M. Dong Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins PLoS Pathog. 10 2014 e1004177
25. S. Prabakaran, W. Tepp, and B.R. DasGupta Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin Toxicon.: Official J. Int. Soc. Toxinology 39 2001 1515 1531
26. A.R. Prevot, and R. Sillioc Activation of botulinum D toxinogenesis by Bacillus licheniformis Ann. Inst. Pasteur (Paris) 96 1959 630 632
27. A.C. Rodloff, and M. Kruger Chronic Clostridium botulinum infections in farmers Anaerobe 18 2012 226 228
28. O. Rossetto, M. Pirazzini, and C. Montecucco Botulinum neurotoxins: genetic, structural and mechanistic insights Nat. Rev. Microbiol. 12 2014 535 549
29. A. Rummel Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity Curr. Top. Microbiol. Immunol. 364 2013 61 90
30. G. Schiavo, O. Rossetto, F. Tonello, and C. Montecucco Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins Curr. Top. Microbiol. Immunol. 195 1995 257 274
31. G. Schiavo, M. Matteoli, and C. Montecucco Neurotoxins affecting neuroexocytosis Physiol. Rev. 80 2000 717 766
32. R.L. Schnaar, R. Gerardy-Schahn, and H. Hildebrandt Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration Physiol. Rev. 94 2014 461 518
33. J. Strotmeier, K. Lee, A.K. Volker, S. Mahrhold, Y. Zong, J. Zeiser, J. Zhou, A. Pich, H. Bigalke, T. Binz, A. Rummel, and R. Jin Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner Biochem. J. 431 2010 207 216
34. R.C. Whitemarsh, M.J. Strathman, L.G. Chase, C. Stankewicz, W.H. Tepp, E.A. Johnson, and S. Pellett Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection Toxicol. Sci.: Official J. Soc. Toxicol. 126 2012 426 435
35. R.C. Whitemarsh, W.H. Tepp, M. Bradshaw, G. Lin, C.L. Pier, J.M. Scherf, E.A. Johnson, and S. Pellett Characterization of botulinum neurotoxin a subtypes 1 through 5 by Investigation of activities in mice, neuronal cell cultures In Vitro. Infect Immun 81 2013 3894 3902
36. H. Yamamoto, T. Ida, H. Tsutsuki, M. Mori, T. Matsumoto, T. Kohda, M. Mukamoto, N. Goshima, S. Kozaki, and H. Ihara Specificity of botulinum protease for human VAMP family proteins Microbiol. Immunol. 56 2012 245 253
37. S. Yamasaki, A. Baumeister, T. Binz, J. Blasi, E. Link, F. Cornille, B. Roques, E.M. Fykse, T.C. Sudhof, and R. Jahn Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin J. Biological Chem. 269 1994 12764 12772